WCCT and Medelis merged to offer U.S. and international clients access to an expanded depth and breadth of clinical research offerings. By combining WCCT’s early phase clinical research sites, pharmacology units and specialty early research programs with the rigorous standards of Medelis’ phase II though IV CRO services (in oncology and other specialty therapeutic areas), we are able to provide a global, specialized team to optimize each area of your clinical development program.
Complete your study on time and on budget with WCCT’s comprehensive offerings:
● Specialized CRO services
● Clinical trial recruitment
● Clinical expertise at each level of your study